半岛bd体育手机客户端 说明
一般描述
A cell-permeable, reversible, substrate competitive inhibitor of protein tyrosine kinases, including autophosphorylation of epidermal growth factor receptor kinase (IC50= 2.6 ?M). The inhibition is competitive with respect to ATP and non-competitive with respect to the phosphate acceptor. Has only a trivial effect on the activity of PKA and PKC (IC50>350 ?M). Inhibits tumor cell proliferation and induces tumor cell differentiation. Produces cell cycle arrest and apoptosis in Jurkat T-leukemia cells. However, it prevents anti-CD3 monoclonal antibody-induced thymic apoptosis. Also inhibits topoisomerase II activityin vitro.
A cell-permeable, reversible, substrate competitive inhibitor of protein tyrosine kinases, including autophosphorylation of epidermal growth factor receptor kinase (IC50= 2.6 ?M). The inhibition is competitive with respect to ATP and non-competitive with respect to the phosphate acceptor. Inhibits tumor cell proliferation and induces tumor cell differentiation. Inhibits exogenous substrate phosphorylation by EGFR kinase and pp60v-srcwith similar potencies (IC50= 20-25 ?M). Has only a trivial effect on PKC and PKA (IC50>350 ?M). Produces cell cycle arrest and apoptosis in Jurkat T-leukemia cells. Prevents anti-CD3 monoclonal antibody-induced thymic apoptosis. Also inhibits topoisomerase II activityin vitro. Blocks oxidative DNA damagein vitro.
包装
50 mg in Plastic ampoule
20 mg in Glass bottle
生化/生理作用
Cell permeable: yes
Primary Target
EGFR kinase
Target IC50: 2.6 ?M against autophosphorylation of epidermal growth factor receptor kinase
Product does not compete with ATP.
Reversible: yes
警告
Toxicity: Standard Handling (A)
其他说明
Constantinou, A., and Huberman, E. 1995.Proc. Soc. Exp. Biol. Med.208,109.
Wei, H., et al. 1995.Proc. Soc. Exp. Biol. Med.208,124.
Wei, H., et al. 1995.Carcinogenesis17,73.
Kobayashi, S., et al. 1994.J. Biol. Chem.269,9011.
Migita, K., et al. 1994.J. Immunol.153,3457.
Spinozzi, F., et al. 1994.Leuk. Res.18,431.
Dhar, A., et al. 1990.Mol. Pharmacol.37,519.
Hill, T.D., et al. 1990.Science248,1660.
Dean, N.M., et al. 1989.Biochem. Biophys. Res. Commun.165,795.
Akiyama, T., et al. 1987.J. Biol. Chem.262,5592.
法律信息
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
基本信息
| 经验(实验)分子式 | C15H10O5 |
| 分子量 | 270.24 |
| MDL编号 | MFCD00016952 |
半岛bd体育手机客户端 性质
| 质量水平 | 100 |
| 测定 | ≥95% (HPLC) |
| 形式 | solid |
| manufacturer/tradename | Calbiochem? |
| 储存条件 | OK to freeze protect from light |
| 颜色 | white |
| 溶解性 | DMSO: 200 mg/mL |
| 运输 | ambient |
| 储存温度 | ?20℃ |
| InChI | 1S/C15H10O5/c16-9-3-1-8(2-4-9)11-7-20-13-6-10(17)5-12(18)14(13)15(11)19/h1-7,16-18H |
| InChI key | TZBJGXHYKVUXJN-UHFFFAOYSA-N |
安全信息
| 象形图 |  |
| 警示用语： | Warning |
| 危险声明 | H302 |
| 预防措施声明 | P264 - P270 - P301 + P312 - P501 |
| 危险分类 | Acute Tox. 4 Oral |
| 储存分类代码 | 11 - Combustible Solids |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
Sigma-Aldrich
m.cnreagent.com
